How much does Ennogen Healthcare International Limited make?

Ennogen Healthcare International Limited reported revenue of £61.6m and a loss of £646k in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Ennogen Healthcare International Limited have?

Ennogen Healthcare International Limited reported an average of 57 employees in the year to 31 Dec 2025.

Is Ennogen Healthcare International Limited profitable?

No — Ennogen Healthcare International Limited reported a loss of £646k in the year to 31 Dec 2025.

Company No. 13097275 · Incorporated 23 Dec 2020

Ennogen Healthcare International Limited

Registered name: ENNOGEN HEALTHCARE INTERNATIONAL LIMITED

Part of Ennogen Holdings Limited group

Ennogen Healthcare International Limited made £61.6m revenue and a £646k loss in the year to 31 Dec 2025.

Ennogen Healthcare International Limited’s revenue grew 19% to £61.6m in the year to 31 Dec 2025, with a loss of £646k and 57 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Dartford; we hold 5 years of its filed accounts.

Full P&L filedSection C · ManufacturingSIC 21100Manufacture of basic pharmaceutical products SIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Dartford, South East
Age: 5 yrs · since 2020
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Revenue

£61.6m

Growth ▲18.7%

Profit

−£646k

Growth ▼113.6%

Profit margin

−1.1%

Gross 67.6%

Employees

Change ▲5.6%

Profit / employee

−£11.3k

Revenue/employee £1.1m

Profitable streak

0yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

5 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2021	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Profit only	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	—	£6.6m	£33.3m	£51.9m	£61.6m
Cost of sales	—	£2.5m	£13.1m	£16.8m	£20m
Gross profit	—	£4.1m	£20.2m	£35.1m	£41.7m
Operating profit	—	−£1.4m	−£1.2m	£9.6m	£4.3m
Profit before tax	—	−£1.4m	−£2.1m	£8.8m	£1.6m
Profit after tax	£0	−£1.5m	−£3.3m	£4.8m	−£646k
Profit (best available)	£0	−£1.5m	−£3.3m	£4.8m	−£646k
Staff costs	—	£789k	£2.9m	£4m	£4.2m
Employees (average)	—	39	47	54	57
Ratios
Profit margin	—	−22.5%	−9.9%	9.2%	−1.1%
Gross margin	—	62%	60.5%	67.6%	67.6%
Revenue per employee	—	£169k	£709k	£961k	£1.1m
Profit per employee	—	−£38.1k	−£70.1k	£88k	−£11.3k
Growth (year on year)
Revenue growth	—	—	▲404.7%	▲55.8%	▲18.7%
Profit growth	—	—	—	—	▼113.6%
Headcount growth	—	—	▲20.5%	▲14.9%	▲5.6%
Balance sheet — indirect signals, not revenue
Cash at bank	—	£5m	£3.2m	£9.9m	£16.9m
Net assets	£1k	£60.9m	£57.5m	£62.3m	£60.4m
Fixed assets	—	£49m	£58.1m	£61.4m	£75m
Current assets	£1k	£13.7m	£21.1m	£36.4m	£49.2m
Debtors	£1k	£2.7m	£10.4m	£13.7m	£16.9m
Deferred income	—	£56.8k	£2.6m	£3m	£6.4m
Cash from operations	−£1k	−£7.3m	—	—	—
Source	Accounts · bulk data Dec 2023	Accounts · bulk data Dec 2023	FullAccounts · bulk data Sep 2025	FullAccounts · bulk data Sep 2025	FullAccounts · bulk data Jun 2026

Derived from the latest filing

How the business works

Profit margin: −1.1%; Profit ÷ revenue.
Gross margin: 67.6%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £1.1m; Revenue ÷ average employees.
Profit per employee: −£11.3k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 121.8%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 10.4%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 27.4%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▼3%; Now £60.4m
Cash at bank: ▲71%; Now £16.9m
Headcount: ▲6%; Now 57
Deferred income: ▲116%; Now £6.4m
Fixed assets: ▲22%; Now £75m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Ennogen Holdings Limitedultimate parent75–100%
Ennogen Investments Ltd75–100%
Ennogen Healthcare International Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (1)

Vitame LtdRev. — · Profit £22.5k

Sister companies (4)

Ennogen IP LtdRev. £4.2m · Profit £944k
Ennogen Healthcare Developments LimitedFigures not disclosed
Ennogen Healthcare UK LtdFigures not disclosed
Progran Health LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit −£646k), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.